Panel Study & Site Management track
Clinical Trial Diversity & Intersectionality: Looking at the Whole Patient
Sat, Apr 26, 2025 · 3:15–4:15 PM CDT Hyatt Regency New Orleans
About this session
In this session, an expert panel with members representing a top 10 industry sponsor; a research and policy center; an independent nonprofit organization; and a pharmaceutical business intelligence provider will share actionable insights on expanding the scope of diversity in clinical trials. The panelists will elaborate on the section of the new U.S. Food and Drug Administration (FDA) diversity plan guidance stating that "FDA advises sponsors to seek diversity in clinical trial enrollment beyond populations defined by race and ethnicity, including other underrepresented populations defined by demographics.
CEU: 1.00 ACRP
Speakers
-
Director of Health Literacy · Center For Info & Study on Clinical Research Participation (CISCRP)
Panelist
-
Director of Health Equity and Clinical Research · Genentech's Chief Diversity Office
Panelist